Education
About Us
Working with TipRanks
Follow Us
PureTech Health PLC (GB:PRTC)
LSE:PRTC
Total Valuation
PureTech Health has a market cap or net worth of 283.42M. The enterprise value is 314.79M.
Market Cap283.42M
Enterprise Value314.79M
Share Statistics
PureTech Health has 240.19M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding240.19M
Owned by Insiders3.43%
Owned by Instutions0.11%
Financial Efficiency
PureTech Health’s return on equity (ROE) is -0.14 and return on invested capital (ROIC) is -41.53%.
Return on Equity (ROE)-14.16%
Return on Assets (ROA)-9.47%
Return on Invested Capital (ROIC)-41.53%
Return on Capital Employed (ROCE)-22.75%
Revenue Per Employee5,200p
Profits Per Employee-916,288.889p
Employee Count90
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of PureTech Health is -10.30. PureTech Health’s PEG ratio is -0.12.
PE Ratio-10.30
PS Ratio902.30
PB Ratio1.46
Price to Fair Value1.46
Price to FCF-6.37
Price to Operating Cash Flow-6.39
PEG Ratio-0.12
Income Statement
In the last 12 months, PureTech Health had revenue of 468.00K and earned -82.47M in profits. Earnings per share was -0.30p.
Revenue468.00K
Gross Profit-81.55M
Operating Income-136.43M
Pretax Income-77.39M
Net Income-82.47M
EBITDA-133.15M
Earnings Per Share (EPS)-0.30
Cash Flow
In the last 12 months, operating cash flow was -120.80M and capital expenditures 0.00p, giving a free cash flow of -120.80M billion.
Operating Cash Flow-120.80M
Free Cash Flow-120.80M
Free Cash Flow per Share-0.50p
Dividends & Yields
PureTech Health pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield-15.69%
Earnings Yield-9.71%
Stock Price Statistics
Beta1.80
52-Week Price Change-41.26%
50-Day Moving Average136.32
200-Day Moving Average153.26
Relative Strength Index (RSI)47.33
Average Volume (3m)890.13K
Important Dates
PureTech Health upcoming earnings date is Apr 24, 2025, TBA.
Last Earnings DateAug 28, 2024
Next Earnings DateApr 24, 2025
Ex-Dividend Date―
Financial Position
PureTech Health as a current ratio of 6.76, with Debt / Equity ratio of 0.05
Current Ratio6.76
Quick Ratio6.76
Debt to Market Cap<0.01
Net Debt to EBITDA9.37
Interest Coverage Ratio-10.84
Taxes
In the past 12 months, PureTech Health has paid 24.86M in taxes.
Income Tax24.86M
Effective Tax Rate-84.55%
Enterprise Valuation
PureTech Health EV to EBITDA ratio is -28.90, with an EV/FCF ratio of -4.81.
EV to Sales681.32
EV to EBITDA-28.90
EV to Free Cash Flow-4.81
EV to Operating Cash Flow-4.82
Balance Sheet
PureTech Health has 500.42M in cash and marketable securities with 144.73M in debt, giving a net cash position of -355.68M billion.
Cash & Marketable Securities500.42M
Total Debt144.73M
Net Cash-355.68M
Net Cash Per Share-1.48p
Tangible Book Value Per Share1.67p
Margins
Gross margin is -12731.33%, with operating margin of -19493.20%, and net profit margin of -8759.60%.
Gross Margin-12731.33%
Operating Margin-19493.20%
Pretax Margin-4813.73%
Net Profit Margin-8759.60%
EBITDA Margin-2357.47%
EBIT Margin-3015.33%
Analyst Forecast
The average price target for PureTech Health is 455.00p, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target455.00p
Price Target Upside262.84%
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast